1Research on the clinical value evaluation of multiple myeloma therapeutic drugs from the perspective of venture capitalYANG Ting-ting, KE Chao-jing, WU Xia, ZHOU Bin1321-13252Research hotspots of natural products base on co-word analysisNI Bing-wei, ZHAO Hong-ping, GU Yue-qing1326-13333A new antiosteoporosis drug:romosozumabLIU Zhao-hui, MA Jian-xiong, MA Xin-long1334-13374Discussion about efficacy endpoints of clinical trials of coagulation factor Ⅷ and Ⅸ for hemophilia on demandRAO Ya-lan, JI Shuang-min, XIONG Wen-xiang, YU Ai-ping, YANG Huan, GAO Chen-yan1338-13425CMC considerations for additional strength biowaiver of oral solid generic drugsHU Yan-chen, KANG Jian-lei1343-13486Establishment and validation of UPLC-MS/MS method for determination of an innovative antitumor drug SM-1 in plasma of Beagle dogsLIU Shu-jie, YU Min, WANG Yu, HUANG Shu-jia, DAN Mo, LI Zuo-gang, GENG Xing-chao, ZHANG He-zhan, YANG Jin-bo, LIU Li1349-13547Application of multivariate analysis method in generic drug quality evaluationZHAO Yu, HU Chang-qin, YAO Shang-chen, YIN Li-hui, LING Xiao-mei1355-13628Recent advances in research on targets and drugs for treatment of non-alcoholic fatty liver diseaseZHOU Zong-tao, DENG Li-ming, HU Li-jun, REN Qiang, ZHANG Lu-yong, LI Zheng1363-13749Progress in clinical application of tyrosine kinase inhibitor osimertinib in non-small cell lung cancerZHANG Cong-hui, LIU Jian1375-138110Epidemiological investigation of echinocandin-resistant CandidaZHANG Wei, HUANG Jing-jing, XIAO Meng, XU Ying-chun1382-138611Discussion about the process quality management of investigator-initiated clinical trialsKANG Mei, LI Xian-chen, HE Hui-chen, QIU Yan, CAO Pei, DING Xue-ying, ZHU Yan-hong, QIAN Bi-yun1387-139012Simultaneous determination of venlafaxine and its metabolite in human plasma by LC-MS/MSZENG Shi, WEI Bo-ping, LI Sha, LIU Chang, XU Xin-ying, LI Xin-xin, YUAN Jun1391-139613Study on bioequivalence of ticagrelor tablets in healthy subjectsCUI Ying-zi, ZHOU Yan-nan, WANG Yuan, YANG Hai-miao1397-140414Effect of Xingnaojing injection on cognitive impairment following anesthesia in aged ratsXIN Hong-ya, SHI Zhen-gang, WANG Ping, WU Li-feng, ZHANG Miao-hong, LI Qiao, YUAN Xiang-zhong, XU Yong-xing, ZENG Gui-rong, WAN Ji-feng1405-141115Study on the compatible stability of cephalosporin injections with Xueshuantong injection (lyophilized)XING Xue, LIU Zhi-dong, WANG Meng1412-141816Determination of three components and fingerprint research in Anisi stellati Fructus by QAMS methodLI Fei-fei, WEI Yue, SONG Meng-jiao, FAN Yi, NING Er-juan, ZHANG Li-xian, ZHANG Tao-tao, LI Zi-hong1419-142417Screening of medium borosilicate glass vials for LPM3480392 injectionXU Wen-wen, SUN Zhen, SUN Yu-tong, LI Jin-ming, CHE Xin, ZHOU Feng-mei, YU Fei, LIU Wan-hui1425-143318Application of PK/PD model combined with Monte-carlo simulation to estimate and optimize dosage regimens for extended spectrum β-lactamases klebsiella pneumoniae infectionLIU Feng, DENG Gui-xin, TANG Lei, LIU Rui-feng1434-1440 